GoI Permits COVID-19 Vaccination For Individuals Above 18 Years Of Age

GoI Permits COVID-19 Vaccination For Individuals Above 18 Years Of Age,Mango News,GoI Permits COVID-19 Vaccination,COVID-19,COVID-19 Vaccination,Government Of India Announced COVID-19 Vaccination Drive In India,Novel Coronavirus,Coronavirus,COVID-19 Vaccination Drive,COVID-19 Vaccination Drive In India,GoI Permits COVID-19 Vaccination Drive,All Above 18 Years Eligible For COVID-19 Vaccination,Covid-19 Vaccination Open To All Above 18 Years From May 1,India To Open Covid-19 Vaccinations To All Above 18 Years,Covid-19 Vaccination For All Above 18 Yrs From 1 May,India Announces Next Phase Of Covid-19 Vaccination,COVID Vaccine Above 18 Years,COVID-19 Vaccination For Above 18 Years Of Age

The Government of India (GoI) announced the beginning of the third phase of the Novel Coronavirus or COVID-19 vaccination drive in India. 

On the 19th of April, the Central Government said, everyone above 18 years old would be eligible for the COVID-19 vaccination. The third phase of the drive which would include individuals above 18 years is scheduled to begin from the 1st of May.

The decision was taken by Prime Minister Narendra Modi, after a series of meetings on Monday, the 19th of April. He held a series of meetings over India’s response to record daily surges in COVID-19 cases with officials and leading doctors, handling the second wave of the Coronavirus infection.

In his meetings yesterday, PM Modi stressed that vaccination was “the biggest weapon” in the fight against the coronavirus and urged doctors to encourage more and more patients to get vaccinated.

PM Modi said, “The Government has been working hard for over a year to ensure that maximum numbers of Indians are able to get the vaccine in the shortest possible of time.”

In addition to allowing adults to take vaccine, the GoI also permitted states to buy doses directly from the vaccine makers in the “liberalised and accelerated Phase 3 strategy of COVID-19 vaccination.” As of now, the Central Government was supplying the doses of two India made vaccines to states and union territories (UTs.) Pricing, procurement, eligibility and administering of vaccines would be flexible in the latest round of the world’s largest vaccination drive. Vaccine manufacturers have been incentivized to scale up their production and release up to 50 % of their supply to states and in the open market at a declared price. The direct supply from manufacturers would be an additional stock for the state governments.

The Nationwide COVID-19 vaccination drive started from the 16th of January with the two made in India vaccines. The two vaccines which were taken by more than 10 crore Indians are the Serum Institute of India (SII) manufactured Covisheild and the Hyderabad based Bharat Biotech International Private Limited manufactured COVAXIN. Recently, the Government of India, in order to increase the production of COVAXIN, permitted Mumbai based state run Haffkine Institute to manufacture COVAXIN.

In January, the drive started with vaccination of front line warriors, in the second phase, senior citizens and people above 45 years old with comorbidities were given the doses. Later, GoI, expanded the eligible people by involving 45 years and above to get vaccination.

Now, from the 1st of May, individuals above 18 would be able to take the vaccination doses

Here are some important new rules:

Vaccine manufacturers would supply 50 % of their monthly Central Drugs Laboratory (CDL) released doses to the Central Government and would be free to supply the remaining doses to state governments and in the open market.

Manufacturers would declare prices in advance for the vaccines supplied to state governments and in the open market.

Based on this price, state governments, private hospitals and industrial establishments can buy vaccine doses from the manufacturers.

Vaccinations at central government centres, provided free of cost, will continue for those eligible currently – health workers, frontline workers and those above 45.

The centre would allocate vaccines from its share to states or union territories based on the number of cases. Vaccine wastage can affect the quota of a state.

The second dose for those eligible currently will be priority.

 

In recent weeks, states like Maharashtra, Delhi and Punjab had called for opening up vaccinations and had also complained about running out of vaccine stocks.

LEAVE A REPLY

Please enter your comment!
Please enter your name here